Dosimetry & Clinical Outcomes in PBM
A recent review examined how wavelength, fluence, output power and treatment schedules varied across PBM studies, highlighting the challenge of inconsistent dosimetry.
Explore research examining how wavelength, irradiance, dose, treatment time and delivery conditions can influence photobiomodulation outcomes.
A review of how wavelength, irradiance, exposure time and protocol design were reported across PBM studies.
Outcomes varied widely, suggesting that similar wavelengths can perform differently under different dosing conditions.
Wavelength is only one part of the protocol and should be interpreted alongside dose and delivery conditions.
A recent review examined how wavelength, fluence, output power and treatment schedules varied across PBM studies, highlighting the challenge of inconsistent dosimetry.
An in-vitro study found dose-dependent responses to near-infrared PBM, illustrating why more delivered energy does not automatically produce a stronger biological response.
A recent review identified wavelength, fluence and pulse mode variability as major barriers to consistent PBM outcomes and protocol standardization.
Which wavelengths were used, and were they delivered alone or in combination?
How much optical power was delivered per unit area?
How long was each exposure, and how often was treatment repeated?
How did wavelength, irradiance and exposure time combine under the study protocol?
PBM studies may use very different wavelengths, irradiance levels, treatment durations, distances and device designs. Similar wavelengths do not necessarily mean that two protocols deliver the same treatment conditions.
Parameter findings should be interpreted within the specific device, protocol, tissue model and outcome measures used in each study.